Subcutaneous Daratumumab Administration in the Thigh Vs Abdomen in Plasma Cell Disorders

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Subcutaneous Daratumumab Administration in the Thigh Vs Abdomen in Plasma Cell Disorders	Neoplasms by Histologic Type, neoplasm, plasma cell neoplasm	Recruiting	Phase 1 / Phase 2	2025-10-29		NCT07075510

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Johnson & Johnson	34
University of Maryland, Baltimore	198

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University of Maryland Greenebaum Comprehensive Cancer Center	Baltimore	United States	20

Clinical trials